Mercy Vascular Research

The Mercy Clinic Heart and Vascular Electrophysiology at Mercy Heart Hospital in St. Louis, MO are involved in a number of clinical trials that allow us to provide minimally invasive and effective treatment options for patients with aortic diseases. Our mission in utilizing clinical trials is to provide excellent, compassionate health care through outstanding patient service.

 

Drs. Vito Mantese, Richard Pennell, Scott Westfall, and Ketan Desai are at the forefront of all aortic disease treatments. They receive national distinction for their ability to treat complex aortic problems using techniques and devices available to only a small number of facilities in the United States. As participants in exclusive aortic disease clinical trials investigating new devices for the treatment of thoracic and abdominal aortic diseases, Mercy provides patients with the most cutting-edge technology available for patients with unique and challenging vascular conditions. 

 

Mercy Clinic Heart and Vascular Electrophysiology is also involved in clinical trials that allow patients an option to receive stents to treat carotid artery and peripheral vascular disease. This allows patients a safe, effective, minimally invasive treatment option. Stents are effective in opening up blockages in the carotid artery to increase blood flow to the brain to prevent strokes and in treating blockages in leg arteries to address symptoms of claudication (pain and weakness in the legs). The use of stents typically minimizes patient recovery time and is less invasive than an open surgical procedure.

 

For more information about available aortic disease clinical trials and vascular treatments, please contact the Mercy Clinic Heart and Vascular Electrophysiology located at 625 S. New Ballas, Suite 7063. The phone number is 314-251-4200.